Companies: 10,795·Total market cap: $144.5T
Crescita Therapeutics Inc.

Crescita Therapeutics Inc.

CTX.TOTSXHealthcare● Active
$0.79
+$0.00(+0.00%)
Market Cap$14705011
P/E Ratio
52W High$0.79
52W Low$0.4
Overview

Crescita Therapeutics Inc. (CTX.TO) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CTX.TO · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.02ctx.to eps ttm · ctx.to earnings per shareEarnings history
PE Ratio (TTM)ctx.to pe ratio ttm · ctx.to price to earningsPE Ratio deep dive
Revenue (TTM)$23.2Mctx.to revenue ttm · ctx.to annual revenueFull revenue history
Dividend YieldNo Dividenddoes ctx.to pay dividends · ctx.to dividend yieldDividend history
Shares Outstanding18.9Mctx.to shares outstanding · ctx.to floatShares outstanding history
Next EarningsAug 5, 2026Est.ctx.to earnings date · ctx.to next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$21.1M▲ +7.85% YoY
202320242025
crescita therapeutics inc. revenue · ctx.to revenue 2025
FY 2025Net Income-$92000.00▲ +96.65% YoY
202320242025
crescita therapeutics inc. net income · ctx.to profit 2025
FY 2025EPS$-0.00▲ +96.50% YoY
202320242025
ctx.to eps · crescita therapeutics inc. earnings per share 2025
TTM:Revenue: $23.2MNet Income: -$320000.00EPS: $-0.02View income statement →

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+3.95%
3M+75.56%
YTD+64.58%
1Y+64.58%
5Y+8.22%

About Crescita Therapeutics Inc.

CEOSerge Verreault
IPO DateJul 10, 2018
Employees71
CountryCA

Crescita Therapeutics Inc. a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates th…

what is crescita therapeutics inc. · ctx.to stock overview · crescita therapeutics inc. company profile · who is crescita therapeutics inc. ceo · ctx.to TSX · crescita therapeutics inc. headquarters · crescita therapeutics inc. business segments

About Stock Overview & Key Data

Crescita Therapeutics Inc. (CTX.TO) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on TSX since Jul 10, 2018. As of the latest trading session, CTX.TO stock price is $0.79, with a market capitalization of $14.7M. The stock has returned +64.58% over the past 12 months and +64.58% year-to-date.

In fiscal year 2025, Crescita Therapeutics Inc. reported revenue of $21.1M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Crescita Therapeutics Inc. (CTX.TO) stock price is $0.79. The stock is traded on TSX under the ticker symbol CTX.TO. The 52-week range is $0.40 – $0.79.

CTX.TO stock priceCTX.TO quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice